Innovations in Respiratory Care Fueling the Ventilator-Associated Pneumonia (VAP) Market
The Ventilator-associated pneumonia (VAP) market is evolving rapidly, with an anticipated market share projected to soar from $1,957.74 million in 2024 to $3,137.49 million by 2035. This impressive growth rate of 10.2% CAGR is indicative of a broader shift in healthcare dynamics focused on enhancing patient safety and minimizing hospital-acquired infections. The significant demand for effective...
0 Comments 0 Shares 53 Views 0 Reviews